The novel therapy of the medication represents a major development in the handling of the condition. Different to existing drugs, tirzepatide targets dual pathways – GLP-1 and GIP – resulting in enhanced glucose https://tirzepatide-peptide094700.59bloggers.com/42362970/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment